Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group. Andre T, Vernerey D, Im SA, Bodoky G, et al. Ann Oncol 2020;31:246-256.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Andre T, Vernerey D, Im SA, Bodoky G, et al. Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group. Ann Oncol 2020;31:246-256.
PMID: 31959341